Franklin Resources Inc Homology Medicines, Inc. Transaction History

Franklin Resources Inc

$304 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.84 - $1.43 $9,109 - $15,508	-10,845 Reduced 20.92%	41,000 $47,000
Q3 2022 Nov 14, 2022	BUY	$1.55 - $3.01 $26,598 - $51,651	17,160 Added 49.47%	51,845 $83,000
Q2 2022 Aug 11, 2022	SELL	$1.39 - $3.12 $23,482 - $52,709	-16,894 Reduced 32.75%	34,685 $68,000
Q4 2021 Feb 11, 2022	SELL	$3.64 - $7.78 $440 - $941	-121 Reduced 0.23%	51,579 $188,000
Q3 2021 Nov 12, 2021	BUY	$6.01 - $8.71 $310,717 - $450,307	51,700 New	51,700 $407,000

Q4 2020 Feb 10, 2021	SELL	$8.92 - $13.29 $2.89 Million - $4.31 Million	-324,400 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$9.94 - $16.59 $9,582 - $15,992	-964 Reduced 0.3%	324,400 $3.47 Million
Q2 2020 Aug 13, 2020	SELL	$12.07 - $19.34 $7,073 - $11,333	-586 Reduced 0.18%	325,364 $5.22 Million
Q1 2020 May 13, 2020	SELL	$12.5 - $22.04 $469,375 - $827,602	-37,550 Reduced 10.33%	325,950 $5.07 Million
Q3 2019 Nov 14, 2019	SELL	$14.74 - $22.28 $1,474 - $2,228	-100 Reduced 0.03%	363,500 $6.58 Million
Q2 2019 Aug 14, 2019	SELL	$18.35 - $30.34 $2.04 Million - $3.36 Million	-110,900 Reduced 23.37%	363,600 $7.12 Million
Q1 2019 May 14, 2019	BUY	$19.76 - $29.57 $1.2 Million - $1.8 Million	60,800 Added 14.7%	474,500 $13.2 Million
Q4 2018 Feb 12, 2019	BUY	$18.39 - $26.3 $366,604 - $524,290	19,935 Added 5.06%	413,700 $9.25 Million
Q3 2018 Nov 13, 2018	BUY	$15.54 - $22.86 $156,099 - $229,628	10,045 Added 2.62%	393,765 $9 Million
Q2 2018 Aug 14, 2018	BUY	$16.49 - $21.55 $968,292 - $1.27 Million	58,720 Added 18.07%	383,720 $7.83 Million
Q1 2018 May 10, 2018	BUY	$18.66 - $18.7 $6.06 Million - $6.08 Million	325,000 New	325,000 $6.08 Million

Others Institutions Holding FIXX

# of Institutions

Shares Held

66.2K

Call Options Held

Put Options Held

View Full List

About Homology Medicines, Inc.

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

More about FIXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account